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LETTERS TO THE EDITORWHAT IS THE CULPRIT IN
CORONARYANOMALIES?
To the Editor:
I read with great interest and excite-
ment the recent report by Bartoli and
colleagues1 concerning the mecha-
nism of ischemia in anomalous
origination of a coronary artery.
Anomalous left coronary artery aris-
ing from the opposite sinus of Val-
salva (called L-ACAOS when the
involved artery has an intramural
course2) is one of the most common
causes of sudden cardiac death in the
young, as observed in United States
military recruits (mean age of 19
years).3
The true cause and individual case
severity of anomalous coronary origi-
nation have been the elusive ‘‘holy
grail’’ sought by many investigators.
This search has been persistently
marred by inadequate evidence and
frustrating uncertainty on clinical
grounds. The report of a calf with
such an anomaly, studied by expert in-
vestigators with amazing means and
dedication, is therefore a welcome
event. Bartoli and colleagues1 hypoth-
esized that ischemia (at least during
their experiments) was ‘‘present and
caused by the course of this anoma-
lous artery in the space between the
aorta and pulmonary artery.’’ Aortog-
raphy is not a proper method for
studying the coronary course in this
location, however, and ischemia was
not well demonstrated by Bartoli and
colleagues’ improvised protocol in
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The Journaldocumenting the flow reserve but not
ischemia). Electrocardiography is not
an acceptable or quantifiable marker
of ischemia (in Figure 1 of Bartoli
and colleagues’ report,1 the T wave
seems to be negative in the 3 tracings,
in the absence of ST-segment depres-
sion). Additionally, the current pre-
vailing opinion is that the cause of
ischemia in this type of coronary
anomaly (L-ACAOS or the similar en-
tity R-ACAOS) is best studied with in-
travascular ultrasonography, which
can satisfactorily document in vivo
the severity of obstruction at baseline
or during exercise.4,5 Flow velocity
is an interesting means of evaluation,
but flow cannot be quantified unless
accompanied by appropriate data
concerning the variable baseline and
exercise-induced cross-sectional area
of stenosis.
Bartoli and colleagues1 are to be
congratulated for their admirable at-
tempt at taking a new approach to
this fascinating subject. It seems to
me, however, that clarifying the pa-
thology requires study of a large clini-
cal population that has been properly
evaluated for severity of obstruc-
tion—correlated with symptoms—
and for empirical response to the elim-
ination of intramural stenosis (by
means of stent angioplasty or surgical
correction).
My group at the Texas Heart Insti-
tute is completing a multiyear re-
search study of a large case series
(65 patients with R-ACAOS), and we
hope that our findings will substan-
tially advance current knowledge in
this field.
Paolo Angelini, MD
The Center for Coronary Artery
Anomalies
Texas Heart Institute
Houston, Tex
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We thank Dr Angelini for his kind
review of our work. We read his letter
with great interest and welcome the
opportunity to clarify a few methodo-
logical points. Each of his comments
is addressed below.
Until now, the mechanism of myo-
cardial ischemia with an anomalous
coronary artery represented an im-
portant and elusive milestone in
congenital cardiology. Our findings
demonstrated in a calf that an ectopic
left coronary artery that coursed from
the right sinus of Valsalva between
the aorta and the pulmonary trunk
produced myocardial ischemia and
ischemic myocardial remodeling.1
As cardiac metabolic demands in-
creased, compression between the
great vessels increased coronary re-
sistance and decreased coronary
blood flow. These findings provide
insight into a potential mechanism
of myocardial ischemia when a coro-
nary artery courses between the great
vessels and raise additional ques-
tions. To further define the clinical
implications, additional studies are
needed.
We agree that aortography is an in-
appropriate technique to study coro-
nary anomalies. Indeed, in our study
the anomaly was surreptitiously iden-
tified via aortogram during a routine
coronary microembolization proce-
dure to create ischemic heart failure
in a calf. The animal was not usedy c Volume 144, Number 6 1531
Letters to the Editorfor microembolization. Instead, we
obtained institutional approval, and 2
weeks later we performed an open
chest procedure to confirm the diagno-
sis of a coronary anomaly and directly
measure myocardial and coronary
blood flow in this unique experimental
animal.
We agree that electrocardiography
is not the best method to quantify
myocardial ischemia. During the
open chest experiment, electrocardi-
ography was used to monitor the calf
and as supplemental data, not to quan-
tify myocardial ischemia. Ischemia
was assessed by direct measurement
of myocardial blood flow with 2
techniques: (1) We quantified and
mapped regional myocardial blood
flow with 15 mm fluorescent-
labeled microspheres.2,3 During each
experimental condition, a calibrated
blood flow sample was drawn to
define absolute values of flow
(milliliters/minute/gram of tissue).
This well-established technique is
a standard method to directly measure
regional blood flow in an organ of in-
terest.4,5 (2) We also quantified
coronary blood flow with a transit-
time ultrasonic flow probe placed
around the distal left coronary trunk,6
which is a standard method to directly
measure volumetric blood flow in an
artery of interest.5 The probe was cali-
brated against known physical stan-
dards of flow to define absolute
values of blood flow (milliliters/
minute).
In Figure 1 of our article, we pre-
sented myocardial blood flow maps
and cardiac cycle–dependent volu-
metric coronary blood flow. During
a dobutamine stress test, classic signs
of acute myocardial ischemia were
observed. At baseline, the electrocar-
diogram demonstrated an inverted
t-wave, as is typical in normal cattle.7
During the dobutamine challenge,
t-wave depression, a large increase in
the amplitude of the QRS complex,
and moderate ST-segment depression
worsened at higher heart rates. These
findings suggested that increased1532 The Journal of Thoracic andmyocardial metabolic demands exac-
erbated myocardial ischemia with
a dose-response relationship.
Specifically, flow-distribution maps
generated with the microsphere tech-
nique demonstrated a large area of re-
duced myocardial blood flow in the
left ventricular free wall and interven-
tricular septum. During dobutamine
challenge, myocardium supplied by
the anomalous left coronary artery re-
ceived 20% less blood flow than myo-
cardium supplied by the normal right
coronary artery. Likewise, during
phenylephrine-induced hypertension,
coronary blood flow measured with
an ultrasonic flow probe decreased
during systole and early diastole.
In contrast, in normal animals, coro-
nary blood flow increased throughout
the cardiac cycle during hyperten-
sion. Overall, 3 independent find-
ings (ischemic electrocardiographic
changes, reduced regional myocar-
dial blood flow, and reduced volu-
metric left coronary artery blood
flow) documented myocardial ische-
mia and supported the hypothesis
that an ischemic mechanism triggers
sudden death in patients with this
type of coronary anomaly.
To reiterate, we directly measured
volumetric coronary blood flow
(milliliters/minute) and regional myo-
cardial blood flow (milliliters/minute/
gram of tissue) with 2 widely ac-
cepted techniques. We did not use
flow velocity (centimeters/second),
which is less accurate. This was a ma-
jor strength of our study. Combined
with high-fidelity aortic root blood
pressure measurements, we calcu-
lated coronary arterial resistance
throughout the cardiac cycle. In nor-
mal animals, hypertension decreased
coronary resistance and increased cor-
onary blood flow during systole and
early diastole. However, in the animal
with the ectopic coronary, the oppo-
site occurred. Systolic and early dia-
stolic expansion of the aortic root
and pulmonary trunk compressed the
segment of the left coronary artery
that coursed between the great vesselsCardiovascular Surgery c December 20and produced a pathologic pattern of
coronary blood flow.
Intravascular ultrasound (IVUS)
will certainly assist in further docu-
menting this phenomenon. With
IVUS, it should be possible to quan-
tify real-time changes in the coronary
cross-sectional area as the anomalous
coronary is compressed between the
great vessels. However, IVUS cannot
directly measure coronary or regional
myocardial blood flow, cannot quan-
tify ischemia, and may only be useful
to visualize cardiac cycle–dependent
changes in coronary lumen size.
Importantly, in our study we used
multiple histologic and molecular
techniques to confirm that prior ische-
mia produced chronic remodeling in
myocardium supplied by the ectopic
coronary. The classic pattern of patchy
fibrosis and myocyte hypertrophy was
observed. Increased capillary density
and collateralization suggested
ischemia-induced neovascularization.
Abnormal numbers of apoptotic nuclei
in the myocardium likely represented
transient inflammatory cells. Taken to-
gether, these findings suggested that
episodic ischemic injury produced
chronic myocardial remodeling.
Consequently, in patients with this
anomaly, a remodeled and electrically
unstable myocardial substrate that is
predisposed to ventricular arrhythmia
may trigger sudden death.
A large clinical study is needed to
further investigate this phenomenon.
Dr Angelini’s contributions to the
field of coronary anomalies are unsur-
passed,8 and there is no investigator
better suited to undertake this impor-
tant task. We commend Dr Angelini
and eagerly await the results of his
study. We hope that our small contri-
bution has complemented his efforts.
In summary, we are encouraged by
DrAngelini’s enthusiasm and appreci-
ate his interest in this project. Our
study documented a pattern of abnor-
mal coronary artery resistance and
myocardial ischemia with an anoma-
lous coronary artery from the right si-
nus of Valsalva. Multiple quantitative12
TABLE 1. Stress and immunologic responsemarkers assessedat timed intervals fromtheprocedure
for spontaneous secondarypneumothorax inawakepatients (n¼ 14) andnonawake controls (n¼ 17)
Preoperative
Postoperative
12 h 24 h 48 h
Cortisol (mg/dL)
Awake 13 (8-17) 14 (9-18) 13 (8-18) 12 (9-15)
Control 14 (8-18) 23* (17-43) 21y (13-30) 18z (14-28)
P value .4 .02 .01 .05
Interleukin 6 (pg/mL)
Awake 3.5 (2.5-4.5) 80* (59-121) 61* (41-86) 10z (5-21)
Control 3.4 (2.4-3.8) 124* (82-177) 111* (88-153) 43* (22-91)
P value .5 .03 .01 .001
Natural killer lymphocytes (%)
Awake 11 (7-15) 10 (6-13) 10 (7-13) 11 (6-14)
Control 10 (5-15) 5* (2-7) 6y (3-9) 8z (4-10)
P value .4 .01 .02 .06
Values represent medians and interquartile ranges of unpublished data. *P .001 for intragroup significance versus
baseline value. yP .01 for intragroup significance versus baseline value. zP .05 for intragroup significance versus
baseline value.
Letters to the Editormeasurements of coronary blood flow,
regional myocardial blood flow,
systemic hemodynamics, and electro-
cardiography during different physio-
logic conditions confirmed that
coronary compression between the
great vessels produced myocardial is-
chemia. A clinical study is urgently
needed to replicate and clarify the im-
plications of this finding and to gener-
ate standardized treatments for
congenital coronary anomalies. Fi-
nally, we thank the editors of The Jour-
nal of Thoracic and Cardiovascular
Surgery for the opportunity to com-
ment on our work.
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FOR SECONDARY
SPONTANEOUS
PNEUMOTHORAX: ANOTHER
ADVANCEMENT
To the Editor:
With a great and renewed interest,
we read the recent article by Noda
and colleagues.1 They advocated the
usefulness of awake thoracoscopic sur-
gery in treatingpatientswith secondary
spontaneous pneumothorax, listing
various advantages in a total of 57 con-
secutive patients whom they treated.
These advantages compel us to answer
‘‘yes’’ to thequestion in the title of their
article, ‘‘Is there a benefit of awake
thoracoscopic surgery in patients with
secondary spontaneous pneumotho-
rax?’’ Noda and colleagues1of Thoracic and Cardiovascular Surgerappropriately deserve credit for this
growing experience in awake surgery.
In our own personal experience, the
awake surgical treatment of secondary
spontaneous pneumothorax has been
one of the most critical challenges, first
because of the severe and sometime le-
thal underlying lungdisease and second
because of thedeterioratedgeneral con-
dition of the patients, which often
makes them surgically untreatable.
In this setting, we have recently
speculated on the biologic bases of
these clinical advantages. Indeed, our
preliminary observations have shown
that awake procedures may attenuate
the release of stress hormones (corti-
sol) and systemic inflammation bio-
markers (interleukin 6) and preserve
natural killer cell proportion from
the early postoperative period onward
(Table 1). The impairment of immune
function may lead to several adverse
effects, including postoperative infec-
tions, thus explaining better clinical
results seen after awake surgery.
With attention to the particular medi-
cal needs of our patients,we offer awake
surgery and follow the preference of the
patient after adequate information about
technical aspects of the procedure.
Nowadays, we see favorable satisfac-
tion with the procedure among both pa-
tients and referring physicians.y c Volume 144, Number 6 1533
